Volesky Karena D, Villeneuve Paul J
Doctoral student in the Department of Epidemiology, Biostatistics and Occupational Health at McGill University in Montreal, Que.
Associate Professor in the Department of Health Sciences at Carleton University in Ottawa, Ont.
Can Fam Physician. 2017 Jun;63(6):e300-e309.
To examine participation in screening mammography among women aged 40 to 74 and identify which factors are associated with those women who participate in screening.
Secondary analysis of the cross-sectional 2012 Canadian Community Health Survey.
Canada.
A population-based national sample of 18 312 women aged 40 to 74.
Women's participation in screening mammography in the 2 years preceding the 2012 Canadian Community Health Survey; women's preventive health activities (ie, having a regular doctor, a recent physical checkup, and a Papanicolaou test), which were adjusted for sociodemographic factors.
Participation in recent screening mammography was highest among women aged 60 to 69 (70.3%), followed by those aged 50 to 59 (63.4%) and those aged 70 to 74 (58.4%). Almost one-third (31.4%) of women aged 40 to 49 had had a screening mammogram in the past 2 years. Having a regular doctor (odds ratio [OR] = 3.30, 95% CI 2.90 to 3.73), a physical checkup in the past year (OR = 3.06, 95% CI 2.30 to 4.08), or a Pap test in the past 3 years (OR = 3.47, 95% CI 3.18 to 3.79) more than tripled the odds that women had had a recent screening mammogram.
Aside from age being a factor associated with women's participation in screening mammography, factors related to women's health care use (having a regular doctor, a recent physical checkup, and a recent Pap test) demonstrated a stronger association with women aged 40 to 74 having had recent mammograms. The association between women's participation in screening and their preventive health activities implies that the doctor's office is an appropriate venue for conversations regarding the potential benefits and harms of screening mammography.
调查40至74岁女性参与乳腺钼靶筛查的情况,并确定哪些因素与参与筛查的女性相关。
对2012年加拿大社区健康调查的横断面数据进行二次分析。
加拿大。
基于人群的18312名40至74岁女性的全国样本。
2012年加拿大社区健康调查前两年女性参与乳腺钼靶筛查的情况;女性的预防性健康活动(即有固定医生、近期进行过身体检查和巴氏试验),并对社会人口学因素进行了调整。
60至69岁女性近期参与乳腺钼靶筛查的比例最高(70.3%),其次是50至59岁女性(63.4%)和70至74岁女性(58.4%)。40至49岁女性中近三分之一(31.4%)在过去两年内进行过乳腺钼靶筛查。有固定医生(优势比[OR]=3.30,95%置信区间2.90至3.73)、过去一年进行过身体检查(OR=3.06,95%置信区间2.30至4.08)或过去三年进行过巴氏试验(OR=3.47,95%置信区间3.18至3.79)的女性近期进行乳腺钼靶筛查的几率增加两倍多。
除年龄是与女性参与乳腺钼靶筛查相关的因素外,与女性医疗保健利用相关的因素(有固定医生、近期进行过身体检查和近期进行过巴氏试验)与40至74岁女性近期进行乳腺钼靶检查的关联更强。女性参与筛查与其预防性健康活动之间的关联表明,医生办公室是讨论乳腺钼靶筛查潜在益处和危害的合适场所。